Laparoscopic Adjustable Gastric Banding

R. Rajendram; V. R. Preedy

doi:10.1016/B978-0-12-804011-9.00016-9

Laparoscopic Adjustable Gastric Banding

R. Rajendram^*, V. R. Preedy

^*Corresponding author for this work

Nutritional Sciences

King Abdulaziz Medical City- Riyadh

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Citation (Scopus)

Abstract

The introduction of laparoscopic adjustable gastric banding (LAGB) in 1993 transformed the management of chronic obesity. Over 20 years of clinical experience with this day-case surgical procedure has demonstrated that it is effective and safe even in the superobese, adolescents, and older patients. The perioperative mortality is 0-0.1% and excess weight loss (%EWL) is 50-60%. Importantly, the weight loss achieved by LAGB is associated with significant improvements in obesity-related comorbidities. To achieve the best outcomes after LAGB requires the correct laparoscopic technique, an experienced surgical team, a well-engineered device, and intensive long-term follow-up. In this chapter we describe the development of LAGB with respect to its clinical outcomes.

Original language	English
Title of host publication	Metabolism and Pathophysiology of Bariatric Surgery: Nutrition, Procedures, Outcomes and Adverse Effects
Publisher	Elsevier Inc.
Pages	113-117
Number of pages	5
ISBN (Electronic)	9780128040638
ISBN (Print)	9780128040119
DOIs	https://doi.org/10.1016/B978-0-12-804011-9.00016-9
Publication status	Published - 16 Dec 2016

Keywords

Excess weight loss
Financial cost
Gastric banding
Laparoscopic adjustable gastric banding
Obesity
Stomach

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-804011-9.00016-9

Cite this

@inbook{3d72213d61cd4ae5a3dd73a238a287c1,

title = "Laparoscopic Adjustable Gastric Banding",

abstract = "The introduction of laparoscopic adjustable gastric banding (LAGB) in 1993 transformed the management of chronic obesity. Over 20 years of clinical experience with this day-case surgical procedure has demonstrated that it is effective and safe even in the superobese, adolescents, and older patients. The perioperative mortality is 0-0.1% and excess weight loss (%EWL) is 50-60%. Importantly, the weight loss achieved by LAGB is associated with significant improvements in obesity-related comorbidities. To achieve the best outcomes after LAGB requires the correct laparoscopic technique, an experienced surgical team, a well-engineered device, and intensive long-term follow-up. In this chapter we describe the development of LAGB with respect to its clinical outcomes.",

keywords = "Excess weight loss, Financial cost, Gastric banding, Laparoscopic adjustable gastric banding, Obesity, Stomach",

author = "R. Rajendram and Preedy, {V. R.}",

year = "2016",

month = dec,

day = "16",

doi = "10.1016/B978-0-12-804011-9.00016-9",

language = "English",

isbn = "9780128040119",

pages = "113--117",

booktitle = "Metabolism and Pathophysiology of Bariatric Surgery: Nutrition, Procedures, Outcomes and Adverse Effects",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Laparoscopic Adjustable Gastric Banding

AU - Rajendram, R.

AU - Preedy, V. R.

PY - 2016/12/16

Y1 - 2016/12/16

N2 - The introduction of laparoscopic adjustable gastric banding (LAGB) in 1993 transformed the management of chronic obesity. Over 20 years of clinical experience with this day-case surgical procedure has demonstrated that it is effective and safe even in the superobese, adolescents, and older patients. The perioperative mortality is 0-0.1% and excess weight loss (%EWL) is 50-60%. Importantly, the weight loss achieved by LAGB is associated with significant improvements in obesity-related comorbidities. To achieve the best outcomes after LAGB requires the correct laparoscopic technique, an experienced surgical team, a well-engineered device, and intensive long-term follow-up. In this chapter we describe the development of LAGB with respect to its clinical outcomes.

AB - The introduction of laparoscopic adjustable gastric banding (LAGB) in 1993 transformed the management of chronic obesity. Over 20 years of clinical experience with this day-case surgical procedure has demonstrated that it is effective and safe even in the superobese, adolescents, and older patients. The perioperative mortality is 0-0.1% and excess weight loss (%EWL) is 50-60%. Importantly, the weight loss achieved by LAGB is associated with significant improvements in obesity-related comorbidities. To achieve the best outcomes after LAGB requires the correct laparoscopic technique, an experienced surgical team, a well-engineered device, and intensive long-term follow-up. In this chapter we describe the development of LAGB with respect to its clinical outcomes.

KW - Excess weight loss

KW - Financial cost

KW - Gastric banding

KW - Laparoscopic adjustable gastric banding

KW - Obesity

KW - Stomach

UR - http://www.scopus.com/inward/record.url?scp=85024140250&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804011-9.00016-9

DO - 10.1016/B978-0-12-804011-9.00016-9

M3 - Chapter

SN - 9780128040119

SP - 113

EP - 117

BT - Metabolism and Pathophysiology of Bariatric Surgery: Nutrition, Procedures, Outcomes and Adverse Effects

PB - Elsevier Inc.

ER -

Laparoscopic Adjustable Gastric Banding

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this